TGFβ2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

28 results for “TGFβ2”

Trials

View all 11 →

TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors

30 participants · First posted Jul 26, 2021

Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer

20 participants · First posted Feb 10, 2023

A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies

19 participants · First posted Feb 8, 2019

Drugs

View all 13 →

UD TGFβi NK cells

Neutralizing TGFβ1 antibody(University of Virginia)

TGFβR-KO CAR-EGFR T Cells

News

Oncotelic Therapeutics Completes Phase 1 Trial of OT-101/IL-2 Combination for Advanced Solid Tumors

TGFB2 Gene Methylation Identified as Positive Prognostic Biomarker for Pancreatic Cancer

VasoRx's Lipid Nanoparticle Drug Delivery System Targets TGFβ-Related Diseases

Page 1 of 3